Structural connectivity networks in Alzheimer's disease and Lewy body disease
- PMID: 33792194
- PMCID: PMC8119831
- DOI: 10.1002/brb3.2112
Structural connectivity networks in Alzheimer's disease and Lewy body disease
Abstract
Objective: We evaluated disruption of the white matter (WM) network related with Alzheimer's disease (AD) and Lewy body disease (LBD), which includes Parkinson's disease and dementia with Lewy bodies.
Methods: We consecutively recruited 37 controls and 77 patients with AD-related cognitive impairment (ADCI) and/or LBD-related cognitive impairment (LBCI). Diagnoses of ADCI and LBCI were supported by amyloid PET and dopamine transporter PET, respectively. There were 22 patients with ADCI, 19 patients with LBCI, and 36 patients with mixed ADCI/LBCI. We investigated the relationship between ADCI, LBCI, graph theory-based network measures on diffusion tensor images, and cognitive dysfunction using general linear models after controlling for age, sex, education, deep WM hyperintensities (WMH), periventricular WMH, and intracranial volume.
Results: LBCI, especially mixed with ADCI, was associated with increased normalized path length and decreased normalized global efficiency. LBCI was related to the decreased nodal degree of left caudate, which was further associated with broad cognitive dysfunction. Decreased left caudate nodal degree was associated with decreased fractional anisotropy (FA) in the brain regions vulnerable to LBD. Compared with the control group, the LBCI group had an increased betweenness centrality in the occipital nodes, which was associated with decreased FA in the WM adjacent to the striatum and visuospatial dysfunction.
Conclusion: Concomitant ADCI and LBCI are associated with the accentuation of LBCI-related WM network disruption centered in the left caudate nucleus. The increase of occipital betweenness centrality could be a characteristic biologic change associated with visuospatial dysfunction in LBCI.
Keywords: alzheimer's disease; graph analysis; lewy body disease; structural connectivity.
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
Nothing to report.
Figures


Similar articles
-
Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.J Alzheimers Dis. 2020;73(3):873-885. doi: 10.3233/JAD-190814. J Alzheimers Dis. 2020. PMID: 31868668
-
Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.Neurology. 2019 Apr 23;92(17):e2015-e2026. doi: 10.1212/WNL.0000000000007373. Epub 2019 Apr 3. Neurology. 2019. PMID: 30944239
-
Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.J Alzheimers Dis. 2021;83(2):545-556. doi: 10.3233/JAD-210669. J Alzheimers Dis. 2021. PMID: 34366356
-
Molecular imaging of dementia.Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Psychogeriatrics. 2012. PMID: 22712644 Review.
-
Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S41-4. doi: 10.1016/S1353-8020(11)70015-3. Parkinsonism Relat Disord. 2012. PMID: 22166451 Review.
Cited by
-
Comparative analysis of white matter signal alterations in dementia with Lewy bodies and Alzheimer's disease: a systematic review and meta-analysis.Front Radiol. 2025 Apr 4;5:1554345. doi: 10.3389/fradi.2025.1554345. eCollection 2025. Front Radiol. 2025. PMID: 40256257 Free PMC article.
-
An Improved Fusion Paired Group Lasso Structured Sparse Canonical Correlation Analysis Based on Brain Imaging Genetics to Identify Biomarkers of Alzheimer's Disease.Front Aging Neurosci. 2022 Jan 6;13:817520. doi: 10.3389/fnagi.2021.817520. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35069181 Free PMC article.
References
-
- Albert, M. S. , DeKosky, S. T. , Dickson, D. , Dubois, B. , Feldman, H. H. , Fox, N. C. , & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 7(3), 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
-
- Barber, R. , McKeith, I. , Ballard, C. , & O'Brien, J. (2002). Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Journal of Neurology, Neurosurgery and Psychiatry, 72(3), 406–407. 10.1136/jnnp.72.3.406 - DOI - PMC - PubMed
-
- Barthel, H. , Gertz, H. J. , Dresel, S. , Peters, O. , Bartenstein, P. , Buerger, K. , & Sabri, O. (2011). Cerebral amyloid‐beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: A multicentre phase 2 diagnostic study. The Lancet Neurology, 10(5), 424–435. 10.1016/s1474-4422(11)70077-1 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical